Page 1 | Search Results | Blood | American Society of Hematology

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Impact of secondary FVIII prophylaxis on joint bleeding and arthropathy in a Hemophilia A mouse model lacking inhibitor response

Lara Monica, Joyce Kimenai, Olga Oleshko, Sonja Werwitzke, Lina Aires, Silvio Wuschko, Jonas Füner, Helmut Paul, Enrico Klotzsch, Paul Schauerte, Larisa Belyanskaya, Sander Botter, Andreas Tiede

Blood (2025) 146 (Supplement 1): 13.

https://doi.org/10.1182/blood-2025-13

Published: 2025

Journal Articles

Using FXIa-triggered thrombin generation to assess the risk of breakthrough bleeding in patients receiving emicizumab for acquired Hemophilia A

Fabius Pelzer, Ella Ertekin, Olga Oleshko, Annika Klingberg, Paul Knoebl, Christian Pfrepper, Richard Greil, Johannes Oldenburg, Ulrich Sachs, Wolfgang Miesbach, Karolin Trautmann-Grill, Katharina Holstein, Hermann Eichler, Patrick Moehnle, Christina Hart, Robert Klamroth, Andreas Tiede, Sonja Werwitzke

Blood (2025) 146 (Supplement 1): 310.

https://doi.org/10.1182/blood-2025-310

Published: 2025

Journal Articles

Vaccine-Induced Thrombocytopenia and Thrombosis (VITT) Antibodies Recognize Neutrophil-Activating Peptide 2 (NAP2) As Well As Platelet Factor 4 (PF4): Mechanistic and Clinical Implications

Lubica Rauova, Andy Wang, Serge Yarovoi, Sanjay Khandelwal, Anand Padmanabhan, Olga Oleshko, Matthew J. Charman, Andreas Tiede, Charles S. Abrams, Matthew D. Weitzman, Gowthami M. Arepally, Douglas B. Cines, Mortimer Poncz

Blood (2021) 138 (Supplement 1): 292.

https://doi.org/10.1182/blood-2021-151685

Published: 2021

Journal Articles

Recombinant VWF fragments improve bioavailability of subcutaneous factor VIII in hemophilia A mice

Nadine Vollack-Hesse, Olga Oleshko, Sonja Werwitzke, Barbara Solecka-Witulska, Christoph Kannicht, Andreas Tiede

Blood (2021) 137 (8): 1072–1081.

https://doi.org/10.1182/blood.2020006468

Published: 2021

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Impact of secondary FVIII prophylaxis on joint bleeding and arthropathy in a Hemophilia A mouse model lacking inhibitor response

Using FXIa-triggered thrombin generation to assess the risk of breakthrough bleeding in patients receiving emicizumab for acquired Hemophilia A

Vaccine-Induced Thrombocytopenia and Thrombosis (VITT) Antibodies Recognize Neutrophil-Activating Peptide 2 (NAP2) As Well As Platelet Factor 4 (PF4): Mechanistic and Clinical Implications

Recombinant VWF fragments improve bioavailability of subcutaneous factor VIII in hemophilia A mice

Email alerts

ASH Publications

American Society of Hematology

Update search

Impact of secondary FVIII prophylaxis on joint bleeding and arthropathy in a Hemophilia A mouse model lacking inhibitor response

Using FXIa-triggered thrombin generation to assess the risk of breakthrough bleeding in patients receiving emicizumab for acquired Hemophilia A

Vaccine-Induced Thrombocytopenia and Thrombosis (VITT) Antibodies Recognize Neutrophil-Activating Peptide 2 (NAP2) As Well As Platelet Factor 4 (PF4): Mechanistic and Clinical Implications

Recombinant VWF fragments improve bioavailability of subcutaneous factor VIII in hemophilia A mice

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only